What insurance policy changes affect CPT 76981?

There are 6 tracked policy changes affecting CPT 76981, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 76981?

Payers that have issued tracked updates for CPT 76981 include: Aetna.

How do I get notified when CPT 76981 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 76981. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 76981?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

76981 — This code describes an ultrasound exam that specifically evaluates the tissue structure and pattern of an organ like the liver or kidney.: Insurance Policy Changes

76981 Insurance Policy Changes

CPT 76981, in plain terms, covers This code describes an ultrasound exam that specifically evaluates the tissue structure and pattern of an organ like the liver or kidney. CPT 76981 is referenced in 6 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 76981 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Noninvasive Tests for Hepatic Fibrosis (CPB 0690, reviewed 2026-06-18)

Aetna·Effective Jun 18, 2026

Aetna has updated its Clinical Policy Bulletin 0690 on noninvasive hepatic fibrosis testing, effective immediately. The policy establishes coverage criteria for four medically necessary tests (transient elastography/FibroScan, FibroTest-ActiTest/HCV-FibroSure, magnetic resonance elastography, and Enhanced Liver Fibrosis test) with frequency limits of no more than twice per year and restrictions on testing within 6 months of liver biopsy. Multiple investigational tests are now explicitly listed as not covered, requiring billing teams to deny or redirect claims for these services.

76981 Insurance Policy Changes

Endoscopic Ultrasonography (CPB 0446, reviewed 2026-07-22)

Noninvasive Tests for Hepatic Fibrosis (CPB 0690, reviewed 2026-06-18)

Non-Invasive Fetal Membranes Rupture Tests (CPB 0757, reviewed 2025-11-12)

Breast Transillumination, Electrical Impedance Scanning (EIS), and Elastography (CPB 0386, reviewed 2026-05-26)

Optical Coherence Tomography and Microelastography for Solid Tumors and Other Selected Indications (CPB 0886, reviewed 2026-03-03)

Non-Invasive Fetal Membranes Rupture Tests (CPB 0757, reviewed 2026-10-21)